Premium
Multidrug resistant miliary tuberculosis during infliximab therapy despite tuberculosis screening
Author(s) -
Gin Alexander,
Dolianitis Con
Publication year - 2014
Publication title -
australasian journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.67
H-Index - 53
eISSN - 1440-0960
pISSN - 0004-8380
DOI - 10.1111/ajd.12053
Subject(s) - medicine , tuberculosis , miliary tuberculosis , infliximab , intensive care medicine , pathology , disease
We describe an unusual case of multidrug‐resistant miliary tuberculosis diagnosed 9 months after the commencement of infliximab treatment for psoriasis despite negative pretreatment tuberculosis screening, including chest X ‐ray and interferon‐gamma release assay. After 4 months' treatment with amikacin, ethambutol, pyrazinamide and moxifloxacin, infliximab was restarted with concomitant anti‐ TB medications. No recurrence of tuberculosis has been detected 12 months after recommencing infliximab.